ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TNDM vs DRTS // OPERATING MARGIN

Tandem Diabetes Care Inc. (NASDAQ) VS. Alpha Tau Medical Ltd. (NASDAQ) • 15-METRIC TALLY: TNDM 4 — DRTS 0
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TNDM VS. DRTS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TNDM DRTS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 53.80% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -2.15% -2.68% +0.53 TNDM /fcf-yield <GO>
Operating Margin ACTIVE -18.50% — — TIE /operating-margins <GO>
Net Profit Margin -20.20% — — TIE /net-margins <GO>
Revenue Growth (YoY) 7.90% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 TNDM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.6 43.6 +16.00 TNDM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.33B $1.21B $121.9M TNDM /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TNDM REV DRTS REV TNDM GROSS % DRTS GROSS % TNDM FCF DRTS FCF
FY 2025 $1.01B $118.4M 53.8% — -$29.7M -$32.8M
FY 2024 $940.2M $100.9M 52.1% — $5.0M -$22.0M
FY 2023 $747.7M $99.9M — — -$31.8M -$18.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TNDM // BETA —
DRTS // BETA —